In inflammatory bowel disease, CXCL10 likely leads to intestinal barrier damage by virtue of its abundance and capability to stimulate myeloid-derived cells to produce tissue-damaging cytokines, such as IL-12, IL-23, and TNF-α (24). Here, CXCL10 is linked to inflammatory bowel disease.